Jialiang Brain Science lands Series D for neurosurgery tech

What's the deal? Jialiang Brain Science, a Chinese company commercialising brain science and neurosurgery technology, has raised a Series D round. Ningbo state-owned assets, Kuanqiao Hengsong, and Saizhi Bole Investment backed the deal.

What's the endgame? The company has built two technology platforms — brain-machine modulation and medical lasers. It uses them to develop devices for a range of neurological diseases.

The signal: A Series D shows investors are betting on later-stage neurotech in China, where state-backed funds increasingly play a role in medical device financing.

Image credit: Generated with Gemini